Individualised Neoantigen Therapy mRNA-4157 (V940) Plus Pembrolizumab Versus Pembrolizumab Monotherapy in Resected Melanoma (KEYNOTE-942): A Randomised, Phase 2b Study

Weber, Jeffrey S; Carlino, Matteo S; Khattak, Adnan; Meniawy, Tarek; Ansstas, George; Taylor, Matthew H; Kim, Kevin B; McKean, Meredith; Long, Georgina V; Sullivan, Ryan J; Faries, Mark; Tran, Thuy T; Cowey, C Lance; Pecora, Andrew; Shaheen, Montaser; Segar, Jennifer; Medina, Theresa; Atkinson, Victoria; Gibney, Geoffrey T; Luke, Jason J; Thomas, Sajeve; Buchbinder, Elizabeth I; Healy, Jane A; Huang, Mo; Morrissey, Manju; Feldman, Igor; Sehgal, Vasudha; Robert-Tissot, Celine; Hou, Peijie; Zhu, Lili; Brown, Michelle; Aanur, Praveen; Meehan, Robert S; Zaks, Tal